Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes

Henrickson, 2003, Parainfluenza viruses, Clin Microbiol Rev, 16, 242, 10.1128/CMR.16.2.242-264.2003 Weinberg, 2009, Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization, J Pediatr, 154, 694, 10.1016/j.jpeds.2008.11.034 Hutspardol, 2015, Significant transplantation-related mortality from respiratory virus infections within the first one hundred days in children after hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, 21, 1802, 10.1016/j.bbmt.2015.06.015 Chemaly, 2014, Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies, Clin Infect Dis, 59, S344, 10.1093/cid/ciu623 Lujan-Zilbermann, 2001, Respiratory virus infections in pediatric hematopoietic stem cell transplantation, Clin Infect Dis, 33, 962, 10.1086/322628 Nichols, 2001, Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome, Blood, 98, 573, 10.1182/blood.V98.3.573 Lewis, 1996, Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients, Clin Infect Dis, 23, 1033, 10.1093/clinids/23.5.1033 Baxter, 1977, Maintenance of viability and comparison of identification methods for influenza and other respiratory viruses of humans, J Clin Microbiol, 6, 19, 10.1128/jcm.6.1.19-22.1977 Fishaut, 1980, Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity, J Pediatr, 96, 179, 10.1016/S0022-3476(80)80799-2 Englund, 2013, Safety and infectivity of two doses of live-attenuated recombinant cold-passaged human parainfluenza type 3 virus vaccine rHPIV3cp45 in HPIV3-seronegative young children, Vaccine, 31, 5706, 10.1016/j.vaccine.2013.09.046 Moscona, 2005, Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease, J Clin Invest, 115, 1688, 10.1172/JCI25669 Leen, 2014, Antiviral T-cell therapy, Immunol Rev, 258, 12, 10.1111/imr.12138 Papadopoulou, 2014, Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT, Sci Transl Med, 6, 242ra83, 10.1126/scitranslmed.3008825 Gerdemann, 2013, Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant, Mol Ther, 21, 2113, 10.1038/mt.2013.151 Leen, 2009, Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation, Blood, 114, 4283, 10.1182/blood-2009-07-232454 Leen, 2006, Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals, Nat Med, 12, 1160, 10.1038/nm1475 Koehne, 2015, Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia, Biol Blood Marrow Transplant, 21, 1663, 10.1016/j.bbmt.2015.05.015 O'Reilly, 1997, Biology and adoptive cell therapy of Epstein-Barr virus-associated lymphoproliferative disorders in recipients of marrow allografts, Immunol Rev, 157, 195, 10.1111/j.1600-065X.1997.tb00983.x Karron, 2013, Parainfluenza viruses, 996 Dave, 1994, Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells, Virology, 199, 376, 10.1006/viro.1994.1135 Gerdemann, 2012, Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections, Mol Ther, 20, 1622, 10.1038/mt.2012.130 Stokes, 1992, The complete nucleotide sequence of the JS strain of human parainfluenza virus type 3: comparison with the Wash/47885/57 prototype strain, Virus Res, 25, 91, 10.1016/0168-1702(92)90102-F Naik, 2016, Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes, J Allergy Clin Immunol, 137, 1498, 10.1016/j.jaci.2015.12.1311 Hanley, 2016, A phase 1 perspective: multivirus-specific T-cells from both cord blood and bone marrow transplant donors, Cytotherapy, 18, S8, 10.1016/j.jcyt.2016.03.021 Ma, 2015, Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation, Cytotherapy, 17, 1406, 10.1016/j.jcyt.2015.07.005 Blyth, 2013, Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation, Blood, 121, 3745, 10.1182/blood-2012-08-448977 Micklethwaite, 2008, Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation, Blood, 112, 3974, 10.1182/blood-2008-06-161695 Lehners, 2016, Long-term shedding of influenza virus, parainfluenza virus, respiratory syncytial virus and nosocomial epidemiology in patients with hematological disorders, PLoS ONE, 11, 10.1371/journal.pone.0148258 de Lima, 2014, Prolonged respiratory viral shedding in transplant patients, Transpl Infect Dis, 16, 165, 10.1111/tid.12167 Goya, 2016, Phylogenetic and molecular analyses of human parainfluenza type 3 virus in Buenos Aires, Argentina, between 2009 and 2013: The emergence of new genetic lineages, Infect Genet Evol, 39, 85, 10.1016/j.meegid.2016.01.002 Mizuta, 2014, Molecular evolution of the haemagglutinin-neuraminidase gene in human parainfluenza virus type 3 isolates from children with acute respiratory illness in Yamagata prefecture, Japan, J Med Microbiol, 63, 570, 10.1099/jmm.0.068189-0 Betts, 2006, HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells, Blood, 107, 4781, 10.1182/blood-2005-12-4818 Rooney, 1998, Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients, Blood, 92, 1549, 10.1182/blood.V92.5.1549 Feuchtinger, 2008, Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation, J Immunother, 31, 199, 10.1097/CJI.0b013e31815ef862 Leen, 2008, Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy, J Virol, 82, 546, 10.1128/JVI.01689-07 Einsele, 2002, Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy, Blood, 99, 3916, 10.1182/blood.V99.11.3916 Busch, 2016, Role of memory T cell subsets for adoptive immunotherapy, Semin Immunol, 28, 28, 10.1016/j.smim.2016.02.001